Authors


Anne Virden

Latest:

Characterizing A Nasal Spray Formulation From Droplet To API Particle Size

The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.



Dave Wood

Latest:

Inside Experic: Revolutionizing CDMO & Clinical Packaging Services

Dave Wood, CEO at Experic, discusses how decades of expertise with advanced technologies helps pharmaceutical and biotech partners bring products to market faster.


Tiffany Baker

Latest:

Developing an Optimized Risk Assessment Portfolio—The Quality Risk Management Master Plan

A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach.


R. Gary Hollenbeck

Latest:

Are You Ready for REMS?

A book offers a detailed introduction to the new area of risk evaluation and mitigation strategies.


Alexander Rodriguez

Latest:

Analytical Strategies for Cell and Gene Therapy Development

Developing bioassay methods requires a new approach for cell and gene therapy drug development.


Genizer

Latest:

Liposome Extruders

Liposome extruders are mainly used for the liposome formulation and achieving uniform size distributions. It is an ideal instrument to generate nanoscale liposome formulations, and to prepare exosomes and artificial cell membranes. By utilizing the tracked-etched filter membranes, the liposome extruders are capable


Marcel Velterop

Latest:

Outsourcing: The Indian Perspective

India has evolved from a low-cost region to an area with extensive technical capability and high quality standards.


Timothy Riley, PhD

Latest:

The Benefits and Challenges of PEGylating Small Molecules

Polyethylene glycol (PEG) conjugation is a highly effective technical and commercial strategy to develop macromolecules. The authors explain the benefits and process of PEGylation and how it may be applied to small molecules.


Eric VanNess

Latest:

Coating and Taste Masking with Shellac

The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.



Enrico Modena

Latest:

Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1

AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.


Lai Yeo Lian

Latest:

Setting Cleaning Validation Acceptance Limits for Topical Formulations

There is a need for current cleaning validation methods to be used for topical formulations. The authors highlight the issues and challenges encountered.


Surya Singh

Latest:

Pelletization: Revolutionizing Drug Formulation and Delivery

Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.


Stevanato Group

Latest:

Delivering added value in auto-injectors through strategic supply chain partnership

Stevanato Group’s integrated offering addressing mAbs challenges includes Aidaptus®, a 2-step single-use auto-injector accommodating 1mL and 2.25mL PFSs in the same base device, supporting a range of drug viscosities for reliable delivery.


Shailesh Vengurlekar

Latest:

Establishing a Framework for Reliable Pharma Labeling

By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.


Jeff Scholten

Latest:

Coating and Taste Masking with Shellac

The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.



Nano PharmaSolutions, Inc.

Latest:

Physical Nanoformulation for Solubility Enhancement of Poorly Soluble Drugs

Nano PharmaSolutions developed a new nanoformulation for improving solubility of drug molecules, which can save several months of preclinical stage of drug development.


William Bakewell

Latest:

Selecting and Optimizing the Right Manufacturing Partner

Optimizing the use of partners for clinical trials depends on selecting the right contractor.


Nicholas Saraceno

Latest:

FDA Grants Approval to Kedrion to Produce PLGD-1 Therapeutic at Bolognana Plant

FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.


Israel Ortíz

Latest:

Digital Transformation in Pharmaceutical Manufacturing

Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure accurate documentation, and strengthen data integrity.


Michael Hill

Latest:

A Novel Cell Lysis Method to Improve the Viral Vector Manufacturing Process

Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.


Aeshna Amin

Latest:

Variables Affecting Reconstitution Time of Dry Powder for Injection

The authors describe the factors affecting reconstitution time of dry powder for injection and classifies them as intrinsic and extrinsic parameters.


Don Henry

Latest:

High-Quality Communication Enables High-Quality Drug Products

User fee programs have improved FDA’s approval timeline for important therapies.


Toby Blackburn

Latest:

Accelerating Scientific Research Using the Cloud

The “cloud lab” is a virtual laboratory setting that can enable scientists to more quickly advance research.


Stephanie Snow

Latest:

Nitrosamine Impurities in Medicinal Products

Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.


Varanya Chaiyaperm

Latest:

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.


Bora Pharmaceuticals

Latest:

Addressing the complex demands of cell line development

Having a robust Cell Line Development (CLD) strategy is the foundation of biologic production that can propel a project, helping to streamline production while mitigating risk. A tailored and optimized cell line can be instrumental in overcoming development and manufacturing challenges and achieving a competitive advantage in the market with streamlined manufacturing processes. In this eBook, Bora Biologics describes how a robust CLD strategy can help biologics developers anticipate and overcome challenges and streamline production.


Mark D. Argentine

Latest:

Restructuring Method Transfer Through Global Sites

Method-transfer kits help simplify analytical method transfer for global site certifications.